Guangdong Hybribio Biotech Company Overview
- Year Founded
-
2003
- Status
-
Public
- Employees
-
1,990
- Stock Symbol
-
300639
- Investments
-
7
- Share Price
-
$0.82
- (As of Friday Closing)
Guangdong Hybribio Biotech Company General Information
Description
Guangdong Hybribio Biotech Co Ltd is engaged in the Research, development, production, and sales of in vitro diagnostic products such as molecular diagnostic reagents and related instruments, and provision of related services.
Contact Information
Website
www.hybribio.comCorporate Office
- 35/F, Enterprise Square Two, Number. 3 Sheung Yuet Road
- Kowloon Bay
- Hong Kong
- Hong Kong
Corporate Office
- 35/F, Enterprise Square Two, Number. 3 Sheung Yuet Road
- Kowloon Bay
- Hong Kong
- Hong Kong
Guangdong Hybribio Biotech Company Stock Performance
As of 13-Nov-2026, Guangdong Hybribio Biotech Company’s stock price is $0.82. Its current market cap is $529M with 647M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.82 | $0.85 | $0.70 - $1.45 | $529M | 647M | 14.7M | $0.01 |
Guangdong Hybribio Biotech Company Financials Summary
As of 30-Sep-2026, Guangdong Hybribio Biotech Company has a trailing 12-month revenue of $93.1M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 478,226 | 362,090 | 426,791 | 758,155 |
| Revenue | 93,093 | 93,118 | 113,655 | 156,109 |
| EBITDA | 11,990 | (3,494) | (95,307) | 26,388 |
| Net Income | 9,672 | (18,208) | (91,267) | 19,855 |
| Total Assets | 622,518 | 592,803 | 633,277 | 807,746 |
| Total Debt | 26,539 | 12,801 | 11,988 | 7,992 |
Guangdong Hybribio Biotech Company Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Guangdong Hybribio Biotech Company Patents
Guangdong Hybribio Biotech Company Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2025524260-A | A microfluidic chip for sorting live cells | Active | 13-Jun-2023 | ||
| JP-7760736-B2 | A microfluidic chip for sorting live cells | Active | 13-Jun-2023 | ||
| EP-4497811-A1 | Micro-fluidic chip for sorting living cells | Active | 13-Jun-2023 | ||
| EP-4497811-A4 | Micro-fluidic chip for sorting living cells | Active | 13-Jun-2023 | ||
| EP-4497811-B1 | Micro-fluidic chip for sorting living cells | Active | 13-Jun-2023 | B01L3/502746 |
Guangdong Hybribio Biotech Company Signals
Guangdong Hybribio Biotech Company Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Guangdong Hybribio Biotech Company Investments (7)
Guangdong Hybribio Biotech Company’s most recent deal was a Later Stage VC with Salus BioMed. The deal was made on 10-Sep-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Salus BioMed | 10-Sep-2026 | Later Stage VC | Diagnostic Equipment | ||
| MirrorEgo | 24-Mar-2026 | Later Stage VC | Decision/Risk Analysis | ||
| Gaugene | 01-Jul-2022 | Later Stage VC | Diagnostic Equipment | ||
| Ammunition Life Technology | 02-Feb-2021 | Later Stage VC | Diagnostic Equipment | ||
| Uzer Technology | 12-Jan-2021 | Corporate | Diagnostic Equipment |
Guangdong Hybribio Biotech Company ESG
Risk Overview
Risk Rating
Updated December, 31, 2023
27.66 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 15,201
Rank
Percentile
Pharmaceuticals
Industry
of 863
Rank
Percentile
Biotechnology
Subindustry
of 373
Rank
Percentile
Guangdong Hybribio Biotech Company FAQs
-
When was Guangdong Hybribio Biotech Company founded?
Guangdong Hybribio Biotech Company was founded in 2003.
-
Where is Guangdong Hybribio Biotech Company headquartered?
Guangdong Hybribio Biotech Company is headquartered in Hong Kong, Hong Kong.
-
What is the size of Guangdong Hybribio Biotech Company?
Guangdong Hybribio Biotech Company has 1,990 total employees.
-
What industry is Guangdong Hybribio Biotech Company in?
Guangdong Hybribio Biotech Company’s primary industry is Diagnostic Equipment.
-
Is Guangdong Hybribio Biotech Company a private or public company?
Guangdong Hybribio Biotech Company is a Public company.
-
What is Guangdong Hybribio Biotech Company’s stock symbol?
The ticker symbol for Guangdong Hybribio Biotech Company is 300639.
-
What is the current stock price of Guangdong Hybribio Biotech Company?
As of 13-Nov-2026 the stock price of Guangdong Hybribio Biotech Company is $0.82.
-
What is the current market cap of Guangdong Hybribio Biotech Company?
The current market capitalization of Guangdong Hybribio Biotech Company is $529M.
-
What is Guangdong Hybribio Biotech Company’s current revenue?
The trailing twelve month revenue for Guangdong Hybribio Biotech Company is $93.1M.
-
What is Guangdong Hybribio Biotech Company’s annual earnings per share (EPS)?
Guangdong Hybribio Biotech Company’s EPS for 12 months was $0.01.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process